Eli Lilly’s Experimental Alzheimer’s Drug Failed in Large Trial

The drug maker said the drug, solanezumab, had not helped patients with mild symptoms of the disease, a result that may affect prospects for similar tests underway.

from NYT > Health http://ift.tt/2foJeWS
via health&fitness